基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the full record of transactions filed by Huang Michael F.. Officer active across 1 company, notably Soleno Therapeutics INC. In total, 7 reports have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €196k. Activity tracked since 17 July 2024. The latest transaction was filed on 27 March 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Huang Michael F. is a declarant linked to Soleno Therapeutics INC, where he is Sr. VP of Clinical Development. He has 6 filings in total. In the 6 most recent filings we hold, covering the period from 2024-07-19 to 2026-03-31, sales total 196484 EUR and the modal transaction nature is Sale.